Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Preliminary Retrospective and Prospective Cohort Study on a Traditional Chinese Long-term Extreme Fasting

Chao Wang, Ligang Ming, Lijun Jia, Qi Wang, Tingting Cao, Liping Wang, Zijing Zhou, Dan Tong, Wei Li, Yiqing Wu, Hong Ding, Di Liu, Minghui Zhang
doi: https://doi.org/10.1101/2020.03.14.20036111
Chao Wang
1School of Medicine, Tsinghua University, Beijing, China
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ligang Ming
2Cancer Institute of Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lijun Jia
3Nanshan Branch of Qilu Hospital, Yantai, China
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qi Wang
4Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
5Institute of Virology, Chinese Academy of Sciences, Wuhan, China
6Institute of Physical Science and Information Technology, Anhui University, Hefei, China
BSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tingting Cao
1School of Medicine, Tsinghua University, Beijing, China
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liping Wang
2Cancer Institute of Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zijing Zhou
1School of Medicine, Tsinghua University, Beijing, China
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Tong
1School of Medicine, Tsinghua University, Beijing, China
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wei Li
5Institute of Virology, Chinese Academy of Sciences, Wuhan, China
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiqing Wu
1School of Medicine, Tsinghua University, Beijing, China
MSc
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hong Ding
7The 8th Medical Center of Chinese PLA General Hospital, Beijing, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: immunolzhang@hotmail.com liud@wh.iov.cn 13911883299@163.com
Di Liu
4Institute of Microbiology, Chinese Academy of Sciences, Beijing, China
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: immunolzhang@hotmail.com liud@wh.iov.cn 13911883299@163.com
Minghui Zhang
1School of Medicine, Tsinghua University, Beijing, China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: immunolzhang@hotmail.com liud@wh.iov.cn 13911883299@163.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Fasting has long been a ritual or practice in varied religions, and recently, has been noticed to reduce the risk factors of metabolic diseases. In China, varied populations performed a traditional Taoism fasting practice, which lasted for 21-day with <5% calorie intake. However, the safety and applicability of this procedure haven not been investigated.

Methods A total of 144 volunteered participants in six camps following the 21-day fasting (with <5% of normal diet) were investigated. 124 were examined for physical biomarkers and 53 of which also had biochemical markers. Another open label, non-comparative, phase 1/2 prospective cohort study enrolling 20 participants with metabolic diseases was also performed. The physical indices and biochemical biomarkers were collected at varied point of the fasting procedure. Statistical comparison and metagenomic analysis were performed. This study was registered in ClinicalTrials.gov (NCT03193177).

Findings Our preliminary retrospective cohort study showed that no severe adverse event (grade 3 or above) was reported, and all biomarkers fluctuated within the safe ranges, except for the urea acid. The 21-day fasting could significantly reduce BMI and blood pressures. The prospective cohort study of the metabolic diseased participants showed a significant reduction of BMI (3.3±1.0) and systolic blood pressure (28.7±17.8 mmHg) after the fasting procedure. The data also presented significant ameliorations on overweight (16/16), hypertension (11/11) and fatty liver (9/9).

Interpretation The 21-day fasting appeared safe and feasible for both healthy and unhealthy people. It could ameliorate the risk factors associated with hypertension and hyperlipidemia.

Funding This work was supported by National Natural Science Foundation of China and China Overseas-Educated Scholars Development Foundation.

Evidence before this study Fasting has long been a ritual or practice in varied religions. In modern science, it has been noticed that fasting or calorie-restricted diets could benefit for the prevention or treatment of metabolic disorder-associated diseases. In China, the fasting practice, called “Bigu” (literally: avoiding grains), is believed to be capable of prolonging life in Taoism and was also used for medical cure. Compared to the reported fasting practices, the Bigu regimen is a more restricted abstinence, in which the practicers usually experience a continuous 21-day practice with an extremely low-calorie intake (<5% of normal diet). In a rough estimation, there are dozens of Bigu practice camps and over ten thousand practicers per year in China. However, nearly all Bigu camps followed the traditional Taoist procedures but lacked medical and scientific evaluation, which made those practices either mysterious or superstitious to the public.

Added value of this study Our data showed that no severe adverse event was reported during the 21-day fasting procedure, and all biomarkers fluctuated within the safe ranges, except for the urea acid. The 21-day fasting could significantly reduce BMI and blood pressures. The data also presented significant ameliorations on overweight, hypertension and fatty liver. This 21-day fasting appeared safe and feasible for both healthy and unhealthy people. It could ameliorate the risk factors associated with hypertension and hyperlipidemia.

Implications of all the available evidence This preliminary cohort study showed that the long-term extreme fasting was safety to most people and exhibited promising therapeutic effects to hypertension, hyperlipidemia and fatty liver. However, a large cohort study of health-improving effects by long-term extreme fasting is needed.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT03193177

Funding Statement

The study was supported by National Natural Science Foundation of China (numbers 81571532, 81771687 and 81601429). MZ was supported by the China Overseas-Educated Scholars Development Foundation. DL was supported by the National Program for Support of Top-notch Young Professionals.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the data have already been attached in supplementary dataset and the raw data can be accessible once requested.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Preliminary Retrospective and Prospective Cohort Study on a Traditional Chinese Long-term Extreme Fasting
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Preliminary Retrospective and Prospective Cohort Study on a Traditional Chinese Long-term Extreme Fasting
Chao Wang, Ligang Ming, Lijun Jia, Qi Wang, Tingting Cao, Liping Wang, Zijing Zhou, Dan Tong, Wei Li, Yiqing Wu, Hong Ding, Di Liu, Minghui Zhang
medRxiv 2020.03.14.20036111; doi: https://doi.org/10.1101/2020.03.14.20036111
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A Preliminary Retrospective and Prospective Cohort Study on a Traditional Chinese Long-term Extreme Fasting
Chao Wang, Ligang Ming, Lijun Jia, Qi Wang, Tingting Cao, Liping Wang, Zijing Zhou, Dan Tong, Wei Li, Yiqing Wu, Hong Ding, Di Liu, Minghui Zhang
medRxiv 2020.03.14.20036111; doi: https://doi.org/10.1101/2020.03.14.20036111

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Nutrition
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10835)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2969)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5394)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)